Efficacy [qlco]
Safety [hcpp]
micronized fenofibrate [orch, phsu]
Simvastatin [orch, phsu]
Patients [podg]
Primary [qlco]
Hyperlipidaemia [dsyn]
Study [mnob]
Performed [ftcn]
Fenofibrate [orch, phsu]
Second [qnco]
Generation [tmco]
Simvastatin [orch, phsu]
Study [mnob]
Efficacy [qlco]
Drugs [phsu]
Reducing [qlco]
Atherogenesis [patf]
risk factors [qnco]
Hyperlipidaemia [dsyn]
Methods [inpr]
Patients [podg]
Entered [qlco]
Single [popg]
Center [spco]
DOUBLE BLIND [resa]
Trial, Crossover [resa]
Patients [podg]
Type IIb Hyperlipidemia [dsyn]
randomized [resa]
treatment [ftcn]
3 Months [tmco]
Single [popg]
Daily Dose [qnco]
mg% [qnco]
micronized fenofibrate [orch, phsu]
mg% [qnco]
Simvastatin [orch, phsu]
Then [tmco]
Changed [ftcn]
Alternative [cnce]
treatment [ftcn]
treatment [ftcn]
Types [qlco]
ILA [gngm]
Fenofibrate [orch, phsu]
Simvastatin [orch, phsu]
reductions [npop]
Levels [qlco]
Total Cholesterol [lbpr]
Low Density Lipoprotein Cholesterol [bacs, strd]
High density lipoprotein cholesterol level [lbpr]
Increased [qnco]
Drugs [phsu]
Decreased [qnco]
Triglyceride level [lbtr]
Lp(a) [aapp, bacs]
Lipoprotein [aapp, bacs]
Patients [podg]
baseline [bodm]
Values [qlco]
Fibrinogen [aapp, bacs, phsu]
Second [qnco]
treatment [ftcn]
Types [qlco]
Fenofibrate [orch, phsu]
Simvastatin [orch, phsu]
reduction [npop]
Total Cholesterol [lbpr]
Low density lipoprotein cholesterol level [lbpr]
Response [orga]
Treatments [topp]
Levels [qlco]
Triglycerides [bacs, lipd]
Lp(a) [aapp, bacs]
Lipoprotein [aapp, bacs]
Fibrinogen [aapp, bacs, phsu]
confirmed [qlco]
Changing [ftcn]
Alternative [cnce]
treatment [ftcn]
Short-term [tmco]
Study [mnob]
Few [qnco]
adverse effects [ftcn]
Drugs [phsu]
Conclusions [idcn]
Fenofibrate [orch, phsu]
Simvastatin [orch, phsu]
variations [qlco]
Total Cholesterol [lbpr]
Low density lipoprotein cholesterol level [lbpr]
treatment [ftcn]
Simvastatin [orch, phsu]
Capacity [qnco]
Decrease [qlco]
Measures [qnco]
Administered [ftcn]
Fenofibrate [orch, phsu]
Fenofibrate [orch, phsu]
Exhibit [inpr]
Established [qlco]
risk factors [qnco]
Triglyceride [bacs, lipd]
Fibrinogen [aapp, bacs, phsu]
Lp(a) [aapp, bacs]
Lipoprotein [aapp, bacs]
Broad [spco]
Spectrum [qnco]
activity [dora]
Simvastatin [orch, phsu]
